​

Alto Neuroscience Ownership | Who Owns Alto Neuroscience?

OverviewFinancialsChart

Alto Neuroscience Ownership Summary

Alto Neuroscience is owned by 83.57% institutional investors, 7.51% insiders, and 8.92% retail investors.

ANRO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAlto Neuroscience83.57%7.51%8.92%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202481-5.81%22,530,140-1.78%831.15%52-21.21%1344.44%
Sep 30, 20248648.28%22,939,57423.33%851.79%6669.23%9-10.00%
Jun 30, 20245811.54%18,600,67416.67%691.96%39-25.00%10-
Mar 31, 202452-15,943,412-59-52---

Recent Insider Transactions

DateNameRoleActivityValue
Jul 10, 2024Savitz Adam CHIEF MEDICAL OFFICERBuy$38.75K
Jul 09, 2024Savitz Adam CHIEF MEDICAL OFFICERBuy$18.25K
Jul 09, 2024Savitz Adam CHIEF MEDICAL OFFICERBuy$133.83K

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q33-

ANRO Ownership FAQ

Who Owns Alto Neuroscience?

Alto Neuroscience shareholders are primarily institutional investors at 83.57%, followed by 7.51% insiders and 8.92% retail investors. The average institutional ownership in Alto Neuroscience's industry, Biotech Stocks , is 68.48%, which Alto Neuroscience exceeds.

Does Blackrock own Alto Neuroscience?

BlackRock is not among the top 10 institutional shareholders of Alto Neuroscience.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools